Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

NCT01371630

Conditions: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms

NCT07382817

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia

NCT07311746

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT00501826

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

NCT05948943

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, +8 more
Locations: UCSF Benioff Children s Hospital Oakland, California, United States

Childrens Hospital of Orange County Orange, California, United States

Lucile Packard Childrens Hosp Palo Alto, California, United States

Childrens National Medical Center Washington D.C., District of Columbia, United States

View all 60 locations

View Trial Details

Recruiting

Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

NCT04288726

Conditions: Classical Hodgkin Lymphoma, Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Hemic and Lymphatic Diseases, +11 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

NCT06580002

Conditions: Adnexal Diseases, Blood Protein Disorders, Brain Cancer, +104 more
Locations: Chao Family Comprehensive Cancer Center, University of California Irvine Orange, California, United States

View Trial Details

Recruiting

Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia

NCT07133997

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

NCT05371808

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: BCCA - Vancouver Vancouver, British Columbia, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada

Lakeridge Health Oshawa Oshawa, Ontario, Canada

View Trial Details

Recruiting

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

NCT06289673

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: Rady Children's Hospital San Diego, California, United States

Our Lady of the Lakes Regional Medical Center Baton Rouge, Louisiana, United States

Novant Health Presbyterian Hemby Children's Hospital Charlotte, North Carolina, United States

Saint Francis Children's Hospital Tulsa, Oklahoma, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions